Evaluation of anti-wrinkle effect of BB cream N-02

Evaluation of anti-wrinkle effect of BB cream N-02, An intra-individual comparison between half of the face treated and half untreated - Evaluation of anti-wrinkle effect of BB cream N-02, An intra-individual comparison between half of the face treated and half untreated

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000049354

Enrollment

Registered

2022-10-28

Start date

2022-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adult female

Interventions

Apply the test product cream to the right half of the face once a day for 4 consecutive weeks Apply the test product cream to the left half of the face once a day for 4 consecutive weeks

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Subjects with a wrinkle grade of 1 to 3 at the time of screening 2.Healthy Japanese women aged 35 to 59 years at the time of screening 3.Subjects who have been fully informed of the purpose of this study and the test product, and who have given their written consent to participate in the study of their own free will.

Exclusion criteria

Exclusion criteria: 1.Subjects who have a clear difference in wrinkle grades between left and right half of the face at the time of screening 2.Subjects who have factors that will affect the evaluation of this study on the test site (disease such as atopic dermatitis, trauma, burns, inflammation, acne, warts, or traces thereof) 3.Subjects who have a history of medical cosmetic treatment that will affect the evaluation of this study at the test site, or those who plan to receive it during the study period 4.Subjects who have received special treatment (facial treatment, etc.) on the test site within the past 3 months, or those who plan to receive it during the study period 5.Pregnant or breastfeeding 6.Subjects who have experienced severe skin symptoms many times due to the use of cosmetics in the past 7.Subjects who use skin care products that advocate or claim indications related to this test product on the test site 8.Subjects using a product (BB cream) for the same application as the test product on the test site 9.Subjects who use lotion, all-in-one products, or a combination of lotion and all-in-one products only for daily skin care. 10.Subjects who are judged to be ineligible by the principal investigator, etc. with other reasons.

Design outcomes

Primary

Measure	Time frame
Effectiveness 1.Photographic wrinkle grade evaluation 2.Calculation of wrinkle analysis parameters for each replica with 3D analysis equipment	—

Secondary

Measure	Time frame
safety 1.Self-report of subjective symptoms 2.Adverse events	—

Countries

Japan

Contacts

Public ContactTakuya Matsuda

Medical Corporation Hokubukai Utsukushigaoka Hospital Clinical Pharmacology Center

matsuda@ughp-cpc.jp011-882-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026